These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37379539)

  • 41. Acute neuromuscular weakness in the intensive care unit.
    Maramattom BV; Wijdicks EF
    Crit Care Med; 2006 Nov; 34(11):2835-41. PubMed ID: 16932235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive Rehabilitation in Severely Ill Inpatients With COVID-19: A Cohort Study in a Tertiary Hospital.
    Woo H; Lee S; Lee HS; Chae HJ; Jung J; Song MJ; Lim SY; Lee YJ; Cho YJ; Kim ES; Kim HB; Lim JY; Song KH; Beom J
    J Korean Med Sci; 2022 Aug; 37(34):e262. PubMed ID: 36038958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of mobility level of COVID-19 patients undergoing mechanical ventilation support: A single center, retrospective cohort study.
    Nawa RK; Serpa Neto A; Lazarin AC; da Silva AK; Nascimento C; Midega TD; Caserta Eid RA; Corrêa TD; Timenetsky KT
    PLoS One; 2022; 17(8):e0272373. PubMed ID: 35913973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Occurrence, diagnosis, and rehabilitation of intensive care unit-acquired weakness].
    Wang X; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):1020-1024. PubMed ID: 32912423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A combined early cognitive and physical rehabilitation program for people who are critically ill: the activity and cognitive therapy in the intensive care unit (ACT-ICU) trial.
    Brummel NE; Jackson JC; Girard TD; Pandharipande PP; Schiro E; Work B; Pun BT; Boehm L; Gill TM; Ely EW
    Phys Ther; 2012 Dec; 92(12):1580-92. PubMed ID: 22577067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.
    Doiron KA; Hoffmann TC; Beller EM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010754. PubMed ID: 29582429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients.
    Yang T; Li Z; Jiang L; Xi X
    Muscle Nerve; 2021 Jul; 64(1):77-82. PubMed ID: 33831220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated.
    Patel BK; Pohlman AS; Hall JB; Kress JP
    Chest; 2014 Sep; 146(3):583-589. PubMed ID: 25180722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis.
    Hermans G; Van Mechelen H; Clerckx B; Vanhullebusch T; Mesotten D; Wilmer A; Casaer MP; Meersseman P; Debaveye Y; Van Cromphaut S; Wouters PJ; Gosselink R; Van den Berghe G
    Am J Respir Crit Care Med; 2014 Aug; 190(4):410-20. PubMed ID: 24825371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19.
    Gérard M; Mahmutovic M; Malgras A; Michot N; Scheyer N; Jaussaud R; Nguyen-Thi PL; Quilliot D
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection.
    Olezene CS; Hansen E; Steere HK; Giacino JT; Polich GR; Borg-Stein J; Zafonte RD; Schneider JC
    PLoS One; 2021; 16(3):e0248824. PubMed ID: 33788876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of neuromuscular stimulation and individualized rehabilitation on muscle strength in Intensive Care Unit survivors: A randomized trial.
    Patsaki I; Gerovasili V; Sidiras G; Karatzanos E; Mitsiou G; Papadopoulos E; Christakou A; Routsi C; Kotanidou A; Nanas S
    J Crit Care; 2017 Aug; 40():76-82. PubMed ID: 28364678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L; Villadóniga M; González-Rodríguez L; Araque L; Díaz-Cid A; Ruz-Caracuel I; Pian H; Sánchez-Alonso S; Fanjul S; Del Álamo M; Regidor I
    Clin Neurophysiol; 2020 Dec; 131(12):2809-2816. PubMed ID: 33137571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.
    Apostolakis E; Papakonstantinou NA; Baikoussis NG; Papadopoulos G
    J Anesth; 2015 Feb; 29(1):112-21. PubMed ID: 24981564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-infectious and post-acute sequelae of critically ill adults with COVID-19.
    Ibrahim H; Athar S; Harhara T; Elhag SA; MElnour S; Sukkar HH; Kamour AM
    PLoS One; 2021; 16(6):e0252763. PubMed ID: 34138871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term follow-up of quality of life and functional ability in patients with ICU acquired Weakness - A post hoc analysis.
    Sidiras G; Patsaki I; Karatzanos E; Dakoutrou M; Kouvarakos A; Mitsiou G; Routsi C; Stranjalis G; Nanas S; Gerovasili V
    J Crit Care; 2019 Oct; 53():223-230. PubMed ID: 31277049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study.
    Xie Y; Liu S; Zheng H; Cao L; Liu K; Li X
    Biomed Res Int; 2020; 2020():3630568. PubMed ID: 32104689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.